Sofia Venceslau

Senior Project Manager • ReciBioPharm

Dr. Sofia Venceslau is passioned about biochemistry and microbial organisms, with strong experience in USP and DSP of microbial systems and with over 20 publications in the field. Sofia joined GenIbet Biopharmeuticals, now ReciBioPharm, in 2019 where she is involved in an end-to-end solution to clients starting on business development, monitoring process development activities, responsible for the process technology transfer, scaling up and implementation of good manufacturing practices, assisting the success of the client´s project from the bench to clinical trials (phase 1 to 3). The portfolio includes manufacturing processes of different areas (protein vaccines, virus oncolytic vaccines, mRNA, DNA, live microbial products, etc) using different systems (bacteria, yeast, mammalian and insect cells, or in vitro systems).

Also speaking

Gabriella Nilsson Hall

Senior Scientist, Cell Therapy Bioprocessing Team • AstraZeneca

Jacqueline Barry

Chief Clinical Officer • CGT Catapult

Evren Alici

Head of Cell and Gene Therapy Group, Department of Medicine • Karolinska Institutet

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.